Clinical trial
TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or…
NCT00023374 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00023374 |
|---|---|
| Title | TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance |
| Official title | TBTC Study 24: A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | US Department of Veterans Affairs U.S. Fed |
| Status | Completed |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Drug |
| Interventions | Rifampin, Pyrazinamide, Ethambutol, REZ |
| Enrollment | 98 |
| Start date | Aug 1, 2000 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2010 |
| First posted | Sep 10, 2001 |
| Last update posted | Aug 3, 2011 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: